We are live on ! Find out more
CCM

Context Capital Management Portfolio holdings

AUM $5.15B
1-Year Est. Return 1.28%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+1.28%
3 Year Est. Return
+3.38%
5 Year Est. Return
+13.56%
10 Year Est. Return
+42.39%
AUM
$1.49B
AUM Growth
+$242M
Cap. Flow
-$1.1B
Cap. Flow %
-73.99%
Top 10 Hldgs %
26.39%
Holding
321
New
7
Increased
Reduced
2
Closed
40
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUROW
76
Aurora Innovation Warrant
AUROW
$5.5K ﹤0.01%
11,228
CEROW
77
DELISTED
CERo Therapeutics Warrants
CEROW
$5.5K ﹤0.01%
200,000
BRLSW icon
78
Borealis Foods Inc Warrant
BRLSW
$5.39K ﹤0.01%
107,878
RRAC.WS
79
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$5.33K ﹤0.01%
44,429
GTACW
80
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$5.19K ﹤0.01%
173,700
PPYAW
81
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$5K ﹤0.01%
250,000
RFACW
82
DELISTED
RF Acquisition Corp. Warrants
RFACW
$4.97K ﹤0.01%
250,000
ASCBW
83
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
$4.97K ﹤0.01%
700,000
MCAAW
84
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$4.76K ﹤0.01%
153,100
CITEW
85
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$4.71K ﹤0.01%
100,000
HCMAW
86
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$4.71K ﹤0.01%
175,000
BNIXW
87
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
$4.01K ﹤0.01%
320,484
BOCNW
88
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$3.98K ﹤0.01%
198,750
TVGNW icon
89
Tevogen Bio Warrant
TVGNW
$9.45M
$3.93K ﹤0.01%
98,250
EMCGW
90
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
$3.9K ﹤0.01%
300,000
ICUCW
91
SeaStar Medical Holding Corp Warrant
ICUCW
$413K
$3.77K ﹤0.01%
124,107
JTAIW
92
DELISTED
Jet.AI Inc. Warrant
JTAIW
$3.75K ﹤0.01%
93,670
NCACW
93
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$3.75K ﹤0.01%
234,200
BNZIW icon
94
Banzai International Warrant
BNZIW
$3.72K ﹤0.01%
80,979
SHCRW
95
DELISTED
Sharecare, Inc. Warrant
SHCRW
$3.68K ﹤0.01%
159,334
NVACW
96
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$3.58K ﹤0.01%
222,500
MNTN.WS
97
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$3.55K ﹤0.01%
27,315
FTIIW
98
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
$3.52K ﹤0.01%
150,000
ECXWW
99
ECARX Holdings Warrants
ECXWW
$3.52K ﹤0.01%
117,430
FIACW
100
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$3.49K ﹤0.01%
100,050

Similar funds

Context Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Context Capital Management held 321 positions worth $1.49B, up 19% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Context Capital Management withdrew a net $1.1B in Q4 2023, closing 40 positions and reducing 2 holdings. Its most notable exit was Apollo Global Management Series A, an estimated $5.22M position sold in full.

By sector, the portfolio is most concentrated in Financials at 1.5% of assets, down from 2.4% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Context Capital Management opened a new position in Iron Horse Acquisitions Corp Unit worth $653K.

  • Context Capital Management's largest Q4 2023 buy was Iron Horse Acquisitions Corp Unit: 65,000 shares worth $653K.
  • Context Capital Management's biggest Q4 2023 reduction was Alset Capital Acquisition Corp Right, cutting an estimated $8.37K.
  • Context Capital Management fully exited Apollo Global Management Series A in Q4 2023, selling an estimated $5.22M.
  • Context Capital Management's ten largest holdings make up 26% of its $1.49B portfolio in Q4 2023.
  • Context Capital Management opened 7 new positions and closed 40 in Q4 2023.
  • Context Capital Management's portfolio value rose 19% quarter-over-quarter to $1.49B.

Based on Context Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.